title: Concussion in Chronic Traumatic Encephalopathy.
abstract: Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease that occurs in association with repetitive mild traumatic brain injury. It is associated with a variety of clinical symptoms in multiple domains, and there is a distinct pattern of pathological changes. The abnormal tau pathology in CTE occurs uniquely in those regions of the brain that are likely most susceptible to stress concentration during trauma. CTE has been associated with a variety of types of repetitive head trauma, most frequently contact sports. In cases published to date, the mean length of exposure to repetitive head trauma was 15.4 years. The clinical symptoms of the disease began after a mean latency of 14.5 years with a mean age of death of 59.3 years. Most subjects had a reported history of concussions with a mean of 20.3. However, 16 % of published CTE subjects did not have a history of concussion suggesting that subconcussive hits are sufficient to lead to the development of CTE. Overall, the number of years of exposure, not the number of concussions, was significantly associated with worse tau pathology in CTE. This suggests that it is the chronic and repetitive nature of head trauma, irrespective of concussive symptoms, that is the most important driver of disease. CTE and exposure to repetitive head trauma is also associated with a variety of other neurodegenerations, including Alzheimer disease. In fact, amyloid β peptide deposition is altered and accelerated in CTE and is associated with worse disease. Here, we review the current exposure, clinical, and pathological associations of CTE.
authors.affiliation: VA Boston Healthcare System, Boston, MA, 02130, USA, tdstein@bu.edu.
authors.forename: Thor D
authors.initials: TD
authors.lastname: Stein
authors.forename: Victor E
authors.initials: VE
authors.lastname: Alvarez
authors.forename: Ann C
authors.initials: AC
authors.lastname: McKee
mesh_terms: D016229:Amyloid beta-Peptides / Q000378:metabolism; D056352:Athletes; D001265:Athletic Injuries / Q000150:complications*; D001930:Brain Injuries / Q000150:complications* / Q000401:mortality; D020208:Brain Injury, Chronic / Q000209:etiology* / Q000401:mortality; D006801:Humans; D008889:Military Personnel; D019636:Neurodegenerative Diseases / Q000209:etiology*; D000067398:War-Related Injuries / Q000150:complications*
chemical_list: D016229:Amyloid beta-Peptides